Scholl H P, Thiel H J, Schlote T
Universitätsaugenklinik Tübingen Abt. I.
Klin Monbl Augenheilkd. 1999 Sep;215(3):197-200. doi: 10.1055/s-2008-1034698.
Spontaneous orbital hemorrhage is a rare but sight threatening incident. Several causative factors are known. Infrequently, hemorrhagic ocular complications can be associated with heparin therapy. The mechanism can involve a immunologically caused thrombocytpenia. In every hemorrhagic ocular complication which occurs in patients treated with heparin Heparin-induced thrombocytopenia (HIT) must be taken into consideration.
A 76-year-old woman who underwent hip surgery three weeks prior to a spontaneous orbital hemorrhage had been treated with subcutaneous heparin. CT scan of the right orbit showed peribulbar hemorrhage with the main focus retro-lateral of the bulbus. Retrobulbar expansion of the hemorrhage was only slight with no compression of the optic nerve. There was no sign of tumor or anomaly of blood vessels. Blood cell count revealed a marked thrombocytopenia with 8000/microliter. After discontinuation of heparin therapy, thrombocytes' cell counts rised rapidly with 114,000/microliter after three days. Parallel to the normalization of the thrombocytes' cell counts the clinical symptoms disappeared quickly.
Heparin-induced thrombocytopenia as a cause for spontaneous orbital hemorrhage has never been reported before. For differential diagnosis in patients with hemorrhagic ocular complications, HIT must taken into account. The most important measure is counting thrombocytes. In thrombocytopenia, heparin therapy must be discontinued before hemorrhagic or thromboembolic complications occur.
自发性眼眶出血是一种罕见但有视力威胁的事件。已知有多种致病因素。出血性眼部并发症偶尔可与肝素治疗相关。其机制可能涉及免疫性血小板减少。在接受肝素治疗的患者发生的每一例出血性眼部并发症中,都必须考虑肝素诱导的血小板减少症(HIT)。
一名76岁女性,在自发性眼眶出血前三周接受了髋关节手术,此前一直在接受皮下肝素治疗。右侧眼眶CT扫描显示球后出血,主要病灶位于眼球后外侧。出血的球后扩展轻微,未对视神经造成压迫。没有肿瘤或血管异常的迹象。血细胞计数显示明显的血小板减少,为8000/微升。停用肝素治疗后,血小板计数迅速上升,三天后达到114,000/微升。随着血小板计数恢复正常,临床症状迅速消失。
肝素诱导的血小板减少症作为自发性眼眶出血的原因此前从未有过报道。对于出血性眼部并发症患者进行鉴别诊断时,必须考虑HIT。最重要的措施是计数血小板。在血小板减少的情况下,必须在出血或血栓栓塞并发症发生之前停用肝素治疗。